You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

allergic conjunctivitis

Showing 1 - 25 of 3,641
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergic Conjunctivitis Trial in Andover (TL-925, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Andover, Massachusetts
    Andover Eye Associates
Nov 29, 2023

Allergic Conjunctivitis Trial in Taichung (Vitamin D, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Vitamin D
  • Placebo
  • Taichung, Taiwan
    China Medical University Hospital
May 1, 2023

Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • MDI-1228_mesylate Ophthalmic Solution
  • Placebo
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jul 24, 2023

Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,

Not yet recruiting
  • Allergic Conjunctivitis
  • Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
  • +3 more
  • Phoenix, Arizona
  • +2 more
Nov 9, 2022

Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (HPMC-HA eyedrops)

Completed
  • Allergic Conjunctivitis
  • +2 more
  • HPMC-HA eyedrops
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 13, 2023

Seasonal Allergic Conjunctivitis Trial in Andover, Memphis (Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic

Not yet recruiting
  • Seasonal Allergic Conjunctivitis
  • Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
  • +3 more
  • Andover, Massachusetts
  • +1 more
Nov 9, 2022

Allergic Conjunctivitis Trial in Andover (PRT-2761 0.5%, PRT-2761 1%, Patanol)

Completed
Has Results
  • Allergic Conjunctivitis
  • PRT-2761 0.5%
  • +4 more
  • Andover, Massachusetts
    Andover Eye Associates
Oct 13, 2022

Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of

Completed
Has Results
  • Conjunctivitis, Allergic
  • ADX-102 Ophthalmic Drops (0.5%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Dec 14, 2022

Allergic Conjunctivitis Trial in Andover (VSJ-110, Placebo)

Completed
  • Allergic Conjunctivitis
  • Andover, Massachusetts
    Vanda Investigational Site
Apr 26, 2022

Allergic Conjunctivitis, Allergic Rhinitis Trial in Vienna (Eye Drops, Solution in Single-Dose Container)

Completed
  • Allergic Conjunctivitis
  • Allergic Rhinitis
  • Eye Drops, Solution in Single-Dose Container
  • Vienna, Austria
    Vienna Challenge Chamber
Aug 24, 2022

Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (Eye drops for itchy and water eyes)

Completed
  • Allergic Conjunctivitis
  • +2 more
  • Eye drops for itchy and water eyes
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 11, 2023

Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Recruiting
  • Allergic Conjunctivitis
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
May 5, 2022

Allergic Conjunctivitis Trial in Andover (olopatadine HCl ophthalmic solution 0.7%), Fluticasone Propionate, Tears Naturale)

Recruiting
  • Allergic Conjunctivitis
  • olopatadine hydrochloride ophthalmic solution 0.7%)
  • +3 more
  • Andover, Massachusetts
    Andover Eye Associates
Jul 18, 2022

Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

Not yet recruiting
  • Allergic Conjunctivitis
  • rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
  • Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
  • (no location specified)
Apr 4, 2023

Bilateral Conjunctivitis (Disorder) Trial in Pompano Beach (Dexamethasone ophthalmic insert 0.4Mg, 0.2% loteprednol etabonate

Completed
  • Bilateral Conjunctivitis (Disorder)
  • Dexamethasone ophthalmic insert 0.4Mg
  • +2 more
  • Pompano Beach, Florida
    Clinical Research Center of Florida
Apr 6, 2022

Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Completed
  • Allergic Conjunctivitis
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
Jan 3, 2022

Allergic Asthma, Allergy to Cats, Allergy to Dust Mites Trial in Iowa City, Boston (Segmental allergen challenge)

Recruiting
  • Allergic Asthma
  • +4 more
  • Segmental allergen challenge
  • Iowa City, Iowa
  • +1 more
May 26, 2022

Food-specific IgG4-guided Elimination Diets Improve Allergy

Completed
  • Rhinitis, Allergic
  • +4 more
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital，School of Medicine，Zhejiang Universit
    Sep 25, 2023

    Allergic Conjunctivitis Trial in Andover, Memphis (ST266, Saline (0.9% NaCl))

    Completed
    Has Results
    • Allergic Conjunctivitis
    • ST266
    • Saline (0.9% NaCl)
    • Andover, Massachusetts
    • +1 more
    Sep 14, 2021

    Allergic Conjunctivitis Trial in Andover (Bilastine 0.2%, Bilastine 0.4%, Bilastine 0.6%)

    Completed
    Has Results
    • Allergic Conjunctivitis
    • Bilastine 0.2%
    • +3 more
    • Andover, Massachusetts
      Ora Clinical Research Center
    Oct 28, 2021

    Allergic Conjunctivitis Trial in United States (Dexamethasone, 0.4mg, Placebo plug with no drug)

    Completed
    Has Results
    • Allergic Conjunctivitis
    • Dexamethasone, 0.4mg
    • Placebo plug with no drug
    • Colorado Springs, Colorado
    • +5 more
    Sep 9, 2021

    Allergic Rhinitis Due to Grass Pollen, Allergic Conjunctivitis of Both Eyes, Allergic Asthma Trial in Aarhus, Linkoeping (Grass

    Active, not recruiting
    • Allergic Rhinitis Due to Grass Pollen
    • +2 more
    • Grass pollen extract - Alutard Phleum pratense, ALK
    • Aarhus, Central Region, Denmark
    • +1 more
    Jan 12, 2022

    Allergic Conjunctivitis Trial in United States (Bilastine Ophthalmic Solution 0.6%, Ketotifen Ophthalmic Solution 0.025%

    Completed
    Has Results
    • Allergic Conjunctivitis
    • Bilastine Ophthalmic Solution 0.6%
    • +2 more
    • Phoenix, Arizona
    • +5 more
    Nov 16, 2021

    Tyrosine Allergoid Paediatric and Adult Study

    Recruiting
    • Allergic Rhinitis Due to Pollen
    • +2 more
    • MATA trees or MATA grass
    • Augsburg, Germany
      Universitätsklinikum Augsburg
    Jan 10, 2022

    Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)

    Not yet recruiting
    • Allergic Rhinitis
    • Conjunctivitis
    • (no location specified)
    Jun 20, 2022